Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Twenty-six of 388 patients (6.7%) followed prospectively after open-heart surgery developed non-A, non-B hepatitis. Of these 26,12 had an elevated (often fluctuating) serum alanine aminotr...

The chronic sequelae of non-A, non-B hepatitis.

Chronic liver disease and primary liver-cell cancer with hepatitis-associated (australia) antigen in serum

Serums from 55 patients with primary hepatocellular carcinoma were examined for the presence of hepatitis-associated antigen (HAA). Forty-four (80%) had the antigen in their serums; alpha ...

Ralph Wright

Papers

Australia antigen in acute and chronic liver disease.